LABD vs SCHD

ALABD

BSCHD

Measures won1–5SCHD wins · of 6 · 5Y

$10,000 · 5Y$16,941VYM · SCHD $16,267

Lowest cost0.04%VYM · $4 on $10k

Most income6.35%LABD · $635 on $10k

Smallest drop−6.7%VYM · worst fall in 1Y

Held in common[…]LABD and SCHD

LABD

SCHD

Direxion Daily S&P Biotech Bear 3X ETF · $61MSchwab U.S. Dividend Equity ETF · $120B

−68.2%3 years · per year$322 · $17,266+20.0%

−47.7%5 years · per year$391 · $16,267+10.2%

1.08%Expense ratio$108 · $6 on $10k · lower wins0.06%

6.35%12-mo yield$635 · $300 on $10k3.00%

−80.6%Worst dropSmaller wins−6.9%

90.5%VolatilityLower wins11.7%

1–5SCHD wins

$10,000 · 5 yearsAll four, one scale

Shared top holdingsLABD · SCHD

They share no top holdings, or holdings aren’t on file […]

Held in common[…]

End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

All Four

5Y4 funds

#
1	VYM	Vanguard High Dividend Yield ETFRead Desk	0.04%	2.31%	−0.5%	+12.8%	+16.5%	+19.6%	+11.1%	−6.7%	$78.9B
2	BSCHD	Schwab U.S. Dividend Equity ETFRead Desk	0.06%	3.00%	−0.7%	+31.4%	+37.0%	+20.0%	+10.2%	−6.9%	$120.5B
3	ALABD	Direxion Daily S&P Biotech Bear 3X ETFRead Desk	1.08%	6.35%	−7.5%	−64.9%	−75.7%	−68.2%	−47.7%	−80.6%	$61M
4	CGDV	Capital Group Dividend Value ETFRead Desk	0.33%	1.27%	−0.1%	+9.6%	+12.9%	+23.5%	new	−9.7%	$39.5B

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

All Four

5Y4 funds

#
1	VYM	Vanguard High Dividend Yield ETFRead Desk	0.04%	2.31%	−0.5%	+12.8%	+16.5%	+19.6%	+11.1%	−6.7%	$78.9B
2	BSCHD	Schwab U.S. Dividend Equity ETFRead Desk	0.06%	3.00%	−0.7%	+31.4%	+37.0%	+20.0%	+10.2%	−6.9%	$120.5B
3	ALABD	Direxion Daily S&P Biotech Bear 3X ETFRead Desk	1.08%	6.35%	−7.5%	−64.9%	−75.7%	−68.2%	−47.7%	−80.6%	$61M
4	CGDV	Capital Group Dividend Value ETFRead Desk	0.33%	1.27%	−0.1%	+9.6%	+12.9%	+23.5%	new	−9.7%	$39.5B

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

LABD vs SCHD

LABD

Direxion Daily S&P Biotech Bear 3X

$391

SCHD

Schwab U.S. Dividend Equity

$16,267

MeasureLABDSCHD

Fee1.08%0.06%

Cost on $10k a year$108$6

Yield6.35%3.00%

5 years, per year−47.7%+10.2%

3 years, per year−68.2%+20.0%

Worst drop · 1Y−80.6%−6.9%

Volatility · 1Y90.5%11.7%

5–1measures won
SCHD first

Nov 6, 2026 · $10,000 five years ago, dividends reinvested

SCHD vs VIG

YTD

SchwabSCHD

+31.4%

VIGVanguard

+12.1%

+31.4%Year to date+12.1%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 6, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+3.2%

JEPIJ.P. Morgan

+5.3%

+3.2%Year to date+5.3%

12.8%Yield8.1%

$42.6BAssets$46.8B

1–1level

End-of-day Nov 6, 2026

SPYM vs SPY

YTD

SPDRSPYM

+8.8%

SPYSPDR

+8.7%

+8.8%Year to date+8.7%

1.1%Yield1.0%

$182BAssets$819B

2–0SPYM wins

End-of-day Nov 6, 2026

Overlap: LABD, SCHD, CGDV, VYM

Today

22.8%most shared, CGDV and VYM

LABDSCHDCGDVVYM

LABD—[…][…][…]

SCHD[…]—5.9%21.9%

CGDV[…]5.9%—22.8%

VYM[…]21.9%22.8%—

End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

$527most kept, LABD

LABD$635 − $108 = $527

SCHD$300 − $6 = $294

VYM$231 − $4 = $227

CGDV$127 − $33 = $94

KeptFee

End-of-day Nov 6, 2026 · yield in dollars minus the fee